What is Zydelig used for and how does it work?
In the United States, Zydelig is approved to treat relapsed chronic lymphocytic leukemia (CLL) in combination with rituximab, where rituximab is appropriate to use taking into account other health conditions a person may have.
In other countries, such as the European Union, United Kingdom, Canada, Australia, New Zealand, and Switzerland, Zydelig is also approved to treat relapsed follicular B-cell non-Hodgkin lymphoma (FL). Zydelig initially also received accelerated approval to treat FL and relapsed small lymphocytic lymphoma (SLL) in the U.S. in 2014 but this approval was contingent upon further research which has been unable to be undertaken and so approval for these two indications (FL and SLL) in the U.S. was voluntarily withdrawn by the company, Gilead Sciences, Inc., in 2022.
Zydelig cannot be used for first-line treatment of any patient with cancer, including CLL, SLL, FL, or indolent non-Hodgkin lymphomas; it is only approved for relapsed CLL in the United States. It should also not be used if bendamustine is being given with rituximab.
How does Zydelig work?
Zydelig works by blocking the effects of an enzyme called PI3K-delta which enables the growth, migration, and survival of white blood cells but is overactive in blood cancers. By blocking the effects of this enzyme, Zydelig causes the cancer cells to die which delays or stops the progression of the cancer.
References
- Zydelig (idelalisib) [Prescribing Information] Updated 03/Gilead Sciences, Inc. https://www.drugclasses.com/pro/zydelig.html
- Gilead Statement on Zydelig® U.S. Indication for Follicular Lymphoma and Small Lymphocytic Leukemia Foster City, Calif., January 14, 2022
- Gilead https://www.gilead.com/news-and-press/company-statements/gilead-statement-on-zydelig-us-indication-for-follicular-lymphoma-and-small-lymphocytic-leukemia#:~:text=Zydelig%C2%AE%20(idelalisib)%20is%20approved,therapy%20due%20to%20other%20comorbidities.
- Zydelig (idelalisib) European Medicines Agency https://www.ema.europa.eu/en/documents/overview/zydelig-epar-medicine-overview_en.pdf
Read next
Is Zydelig a chemotherapy drug?
Zydelig (idelalisib) is not a chemotherapy drug, but a targeted anticancer treatment taken twice daily by mouth. Targeted drug therapies like Zydelig work by blocking specific pathways that allow the cancer to grow uncontrolled. Zydelig is used in combination with rituximab (Rituxan) to treat chronic lymphocytic leukemia (CLL). Continue reading
What is the success rate of Breyanzi?
Everyone will respond differently to Breyanzi (lisocabtagene maraleucel), and the success rate for someone else may be different than for you. Based on clinical trial data, the complete response rate in patients taking Breyanzi is around 20% to 73%, depending on the condition being treated. Continue reading
What is the survival rate of Kymriah?
Studies are ongoing to monitor the survival rate of patients who received Kymriah (tisagenlecleucel) as a cancer treatment. Currently, the available data shows the survival rate is 87.7% for patients with relapsed or refractory follicular lymphoma at 24 months after the Kymriah infusion, and 43.6% for patients with aggressive B-cell non-Hodgkin’s lymphoma. The 5-year survival rate for patients with advanced B-cell advanced B-cell acute lymphoblastic leukemia is 55%. Continue reading
Related medical questions
- What's the difference between Kymriah and Yescarta?
- What is the success rate of Rituxan (rituximab) in patients with blood cancers?
- What is the difference between Truxima and Rituxan?
- Does Truxima make you gain weight?
- What are the names of the BTK inhibitors?
- What is the cost of Kymriah?
- What is the success rate of Epkinly?
- What is the difference between Rituxan and Rituxan Hycela?
- How is Rituxan Hycela administered?
- What type of drug is Copiktra?
- What type of drug is Yescarta (axicabtagene ciloleucel)?
- How will I feel after a Rituxan infusion?
- How long does it take for Rituxan to work?
- How does the drug Rituxan work?
- How do you prepare for a Rituxan infusion?
- What causes infusion reactions to rituximab?
- Does ibrutinib cause hair loss?
- Is Truxima a chemotherapy drug?
- How is Bendeka different to Treanda?
- How long does it take for Jaypirca to work?
- Is Venclexta (venetoclax) chemotherapy?
- How effective is Venclexta?
- How long do you take Venclexta for?
- How is Arzerra administered and how long to work?
- What is Arzerra used for and how does it work?
- Who makes Leukeran, and where is it made?
- How does Venclexta work?
Drug information
Related support groups
- Zydelig (2 questions, 5 members)
- Idelalisib (1 questions, 4 members)
- Follicular Lymphoma (15 questions, 15 members)
- Non-Hodgkin's Lymphoma (15 questions, 39 members)
- Chronic Lymphocytic Leukemia (CLL) (26 questions, 57 members)
- Leukemia (14 questions, 78 members)